Supernus Pharmaceuticals (SUPN) Return on Sales [ROS] (2011 - 2026)
Supernus Pharmaceuticals' Return on Sales [ROS] was -26.46% in Q2 2026, down 33.80 percentage points from 7.34% a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Supernus Pharmaceuticals' Return on Sales [ROS] was -13.95% through Jun 30, 2026, down 23.60 percentage points year-over-year; for FY2025, it came in at -8.66%, down 21.00 percentage points from FY2024.
- Return on Sales [ROS] shows a five-year change of -42.04 percentage points (FY2020 to FY2025).
- In earlier years, Return on Sales [ROS] was 12.34% in FY2024 (+13.21 pp), -0.87% in FY2023 (-7.78 pp), 6.91% in FY2022 (-7.93 pp) and 14.84% in FY2021 (-18.54 pp).
- Quarterly Return on Sales [ROS] has moved between -31.35% (Q3 2025) and 23.25% (Q3 2024) over five years.
- Compared with a year earlier, Return on Sales [ROS] was higher in two of the last seven quarters, with an average year-over-year change of -11.77 percentage points.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q2 2024 (a gain of 26.38 percentage points); the worst was Q3 2025 (a drop of 54.60 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Supernus Pharmaceuticals | 2.47 Bn | 1.12 Bn | 185.39 Mn | -26.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.46% |
| Dec 31, 2025 | -1.86% |
| Sep 30, 2025 | -31.35% |
| Jun 30, 2025 | 7.34% |
| Mar 31, 2025 | -6.85% |
| Dec 31, 2024 | 12.29% |
| Sep 30, 2024 | 23.25% |
| Jun 30, 2024 | 13.41% |
| Mar 31, 2024 | -2.20% |
| Dec 31, 2023 | -0.61% |
| Sep 30, 2023 | 5.29% |
| Jun 30, 2023 | -12.97% |
| Mar 31, 2023 | 3.37% |
| Dec 31, 2022 | 20.52% |
| Sep 30, 2022 | -0.86% |
| Jun 30, 2022 | 6.67% |
| Mar 31, 2022 | 1.29% |
| Dec 31, 2021 | 3.83% |
| Sep 30, 2021 | 21.96% |
| Jun 30, 2021 | 24.14% |
API Access
Supernus Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();